Scott McCauley
Synthego (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Advanced Radiotherapy Techniques, Cancer Research and Treatments, Head and Neck Cancer Studies
Most-Cited Works
- → Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment(2010)843 cited
- → PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients(2018)244 cited
- → Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer(2015)191 cited
- → Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor(2010)136 cited
- → Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial(2019)118 cited
- → Suppression of the ELO-2 FA Elongation Activity Results in Alterations of the Fatty Acid Composition and Multiple Physiological Defects, Including Abnormal Ultradian Rhythms, in Caenorhabditis elegans(2003)94 cited
- → An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma(2021)78 cited
- → Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease(2010)50 cited
- → Abstract 1744: STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor(2021)15 cited
- → PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia(2016)13 cited